The clinical presentation of SMARCA4‐UT lacks specific manifestations but commonly includes dyspnea, chest pain, weight loss, fatigue, superior vena cava syndromes, and pleural invasion [25]. The gene discussed is SMARCA4; the disease is Superior Vena Cava Syndrome.